MedTrace Logo

ATEM (Alvesco Non-interventional Study)

NCT01147224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2016-12-05

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of Alvesco in patients with persistent asthma including or excluding allergic components over 3 months, especially in the spring season. Alvesco will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of Alvesco .

Conditions

Interventions

DRUG

Alvesco

This is an observational study. Therefore, the physician decides about dosage according to individual needs.

Sponsors & Collaborators

Principal Investigators

  • AstraZeneca AstraZeneca · AstraZeneca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-05-31
Completion
2011-08-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01147224 on ClinicalTrials.gov